4.17
-0.2099(-4.79%)
Currency In USD
| Previous Close | 4.38 |
| Open | 4.41 |
| Day High | 4.55 |
| Day Low | 4.14 |
| 52-Week High | 29.4 |
| 52-Week Low | 3.32 |
| Volume | 22,716 |
| Average Volume | 11,689 |
| Market Cap | 1.7M |
| PE | -0.06 |
| EPS | -64.95 |
| Moving Average 50 Days | 5.6 |
| Moving Average 200 Days | 8.71 |
| Change | -0.21 |
If you invested $1000 in Helius Medical Technologies, Inc. (HSDT) 10 years ago, it would be worth $0.01 as of May 07, 2025 at a share price of $4.17. Whereas If you bought $1000 worth of Helius Medical Technologies, Inc. (HSDT) shares 5 years ago, it would be worth $0.35 as of May 07, 2025 at a share price of $4.17.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Helius Medical Technologies Announces Reverse Stock Split
GlobeNewswire Inc.
Apr 30, 2025 1:00 PM GMT
NEWTOWN, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, anno
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary
GlobeNewswire Inc.
Mar 13, 2025 11:00 AM GMT
--Revelation Neuro, Inc. is focused on advancing development of a Non-Implantable Artificial Intelligence (“AI”) Powered BCI Technology-- --Helius’ existing IP portfolio and extensive data warehouse provides a solid foundation for AI algorithm develo
Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device
GlobeNewswire Inc.
Mar 11, 2025 11:00 AM GMT
--Anthem Blue Cross Blue Shield approves claim for PoNS Device at out-of-network adjusted list price-- --Provides further validation of PoNS pricing-- NEWTOWN, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT)